Increasing Incidence Of Monkey Pox Disease Is Driving The Growth Of The Monkey Pox Testing Market.: Strategic Insights Driving Monkey Pox Testing Market Momentum in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Monkey Pox Testing Market Size By 2025?
In recent times, the market size for monkey pox testing has experienced stable growth. The market, which is projected to escalate from $1.46 billion in 2024 to $1.53 billion in 2025, is predicted to have a compound annual growth rate (CAGR) of 4.8%. The growth throughout the historical period can be attributed to factors such as increased government funding and initiatives, a surge in the demand for rapid testing, enhanced testing capacity, escalated research and development, and heightened public awareness campaigns.

How Big Is the Monkey Pox Testing Market Size Expected to Grow by 2029?
Experts forecast a consistent expansion in the monkey pox testing market in the ensuing years. The market is estimated to reach $1.81 billion by 2029, growing at a compound annual rate (CAGR) of 4.4%. This anticipated growth can be credited to increased healthcare spending, the development of point-of-care (POC) tests, the expansion of at-home testing kits, emphasis on affordability and accessibility, and enhancements in healthcare infrastructure. Other significant trends expected to shape the market in the forecast period encompass the merging of testing with surveillance systems, incorporation with digital health technology, technological progress, integration into public healthcare systems, and developments in diagnostic research.

View the full report here:
https://www.thebusinessresearchcompany.com/report/monkey-pox-testing-global-market-report

Which Key Market Drivers Powering Monkey Pox Testing Market Expansion and Growth?
The escalating occurrence of monkeypox is projected to fuel the expansion of the monkeypox testing market. Monkeypox is an infrequent disease brought about by the monkeypox virus, which is part of the orthopoxvirus genus and related to the smallpox virus. The surge in monkeypox incidents can be attributed to increased human-to-human transmission, worldwide travel, and diminished immunity due to the cessation of smallpox vaccine programs. Monkeypox testing plays a critical role in early identification of infected people, enabling prompt treatment and seclusion to halt further disease dissemination. It is also instrumental in monitoring outbreaks and deciphering the virus's spread patterns. For example, the European Centre for Disease Prevention and Control (ECDC), a government agency based in Sweden, reported that there were 1,152 presumed monkeypox cases from January to April 2022, resulting in 55 fatalities and a case-fatality rate of 4.8% scattered across 54 health zones in 14 provinces. It was also noted that compared to the same timeframe in 2021, there were an extra 138 suspected cases and 14 deaths, yielding a higher case-fatality rate of 10.1%. Consequently, the escalating occurrence of monkeypox is stimulating the expansion of the monkeypox testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18817&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Monkey Pox Testing Market?
Leading firms in the monkey pox testing market are honing their focus on the creation of innovative diagnostic solutions, including saliva-based monkey pox assessments, in order to improve precision, ease of use, and reach. The saliva-based method of testing for monkey pox utilizes a sample of saliva to identify the monkeypox virus. In context, Flow Health, an American medical laboratory, introduced the saliva-based PCR, or polymerase chain reaction test for monkeypox in July 2022. This test has reshaped the process with its more user-friendly and less intrusive virus detection method. The test's high level of sensitivity and specificity, quick amplification of genetic material, and adaptability for a range of uses make it stand out. Its ability to conduct quantitative evaluation of viral quantities and direct detection of the pathogen while making the collection of samples simpler is also notable. One of its striking benefits is the capability of testing people before the manifestation of visible lesions, which is key to early detection and containment of the virus.

What Are the Emerging Segments in the Monkey Pox Testing Market?
The monkey pox testing market covered in this report is segmented -

1) By Technology: Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), Other Technologies
2) By Mode: Laboratory Testing, Point Of Care Testing
3) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Other End-Uses

Subsegments:
1) By Polymerase Chain Reaction (PCR): Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Multiplex PCR
2) By Lateral Flow Assay (LFA): Immunochromatographic Lateral Flow Assays, Rapid Antigen Detection Kits
3) By Other Technologies: ELISA (Enzyme-Linked Immunosorbent Assay), CRISPR-based Testing, Serological Tests (Antibody Detection), Nucleic Acid Sequence-Based Amplification (NASBA)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18817&type=smp

Who Are the Global Leaders in the Monkey Pox Testing Market?
Major companies operating in the monkey pox testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., Aegis Sciences Corporation, Chembio Diagnostics Inc., Flow Health Inc., SeraCare Life Sciences Inc., BioGX Inc., Applied DNA Sciences Inc., CerTest Biotec S.L., Altona Diagnostics GmbH, Creative Biogene Inc., ACON Biotech (Hangzhou) Co Ltd.

Which are the Top Profitable Regional Markets for the Monkey Pox Testing Industry?
North America was the largest region in the monkey pox testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18817

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.